Reporter Sept 20 2019

September 24, 2019

Treating C. diff: new purpose for an old drug?

An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice.

By Paul Govern
September 23, 2019

Tailoring treatment for heart defect

By defining the clinical and genetic factors that predict treatment response, Vanderbilt investigators aim to personalize therapy for a common heart complication in preterm infants.

By Leigh MacMillan
September 20, 2019

UPDATE: Information about 403(b) Plan Settlement

In late August a number of faculty members and other employees received a notice regarding a class action settlement from the Settlement Administrator that has been appointed in the matter.

By VUMC News and Communications
September 19, 2019

Microvilli in motion

Live cell imaging studies have revealed that microvilli — finger-like protrusions on the surface of epithelial cells — move and collide as they form the brush border.

By Anivarya Kumar
September 19, 2019

Gamazon receives NIH Genomic Innovator Award

VUMC’s Eric Gamazon is one of only six investigators to receive an inaugural Genomic Innovator Award from the National Human Genome Research Institute, part of the NIH.

By Leigh MacMillan
The money is still rolling in, but it appears that the Greater Nashville Heart Walk will raise close to $2 million in its fight against heart disease and stroke as well as provide funding for public and professional education and community service programs. The walk, held Sept. 14 on Vanderbilt’s campus, saw teams from VUMC (shown above) join more than 10,000 walkers from more than 140 companies. With $70,000 counted, Vanderbilt University Medical Center teams are near the projected fundraising goal of $75,000. Donations are still being accepted at NashvilleHeartWalk.org.
September 19, 2019

Heart Walk 2019

This year’s Greater Nashville Heart Walk will raise close to $2 million in its fight against heart disease and stroke as well as provide funding for public and professional education and community service programs.

By VUMC News and Communications
September 19, 2019

VUMC’s Blume honored by the University of Amsterdam

The University of Amsterdam has awarded the 2019 Spinoza Chair in medicine to Jeffrey Blume, PhD, associate professor of Biostatistics and Biomedical Informatics at VUMC.
By Paul Govern
September 19, 2019

Study seeks factors that increase risk of toxicant exposure

Vanderbilt researchers hope to identify factors that may make humans more susceptible to toxicant exposure — specifically the presence of pre-existing inflammatory disease.
By Kelsey Herbers
September 19, 2019

Address outlines Pediatrics’ achievements, goals

In his annual State of the Department of Pediatrics address, Steven Webber, MRCP, the department’s chair, detailed the significant growth the department has enjoyed in the past year.
By Christina Echegaray
September 19, 2019

Potential prostate cancer biomarkers

An analysis of more than 140,000 people of European ancestry has identified blood protein biomarkers associated with prostate cancer risk.
By Leigh MacMillan
September 19, 2019

All-in-one pill helps reduce blood pressure, cholesterol

A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study.
By Craig Boerner
September 19, 2019

Genetics key to treating heart muscle disorders: Vanderbilt Prize lecturer

Advances in genetics are leading to new ways to treat cardiomyopathies — devastating heart muscle disorders that lead to heart failure.
By Bill Snyder
September 19, 2019

Security software required for employees’ smartphones, tablets

To help prevent unauthorized data access, Vanderbilt University Medical Center is requiring employees who use their personal smartphones and digital tablets to conduct VUMC business to enroll in mobile device management by Feb. 1, 2020.
By Paul Govern
1 2